Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fosfomycin prostate tissue penetration pilot study before TURP
NL-OMON44736Phase 2Active, not recruiting
- Sponsor
- HagaZiekenhuis
- Start
- May 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of fosfomycin in prostatitis (2 arms), sponsored by HagaZiekenhuis. Primary endpoint: Prostate tissue concentration of fosfomycin relative to target MIC. Started May 2016; status: active, not recruiting.
02
Drugs
fosfomycin
03
Conditions
prostatitis
Beyond the preview
Go deeper on NL-OMON44736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON44736.